# Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery

> **NCT06614010** · PHASE1 · RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 207 (estimated)

## Conditions studied

- Dexmedetomidine
- Fascia Iliaca Block

## Interventions

- **DRUG:** Dexmedetomidine Injection
- **DRUG:** Ropivacaine and Dexmedetomidine
- **DRUG:** Sodium Chloride Injection

## Key facts

- **NCT ID:** NCT06614010
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-05
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 207 (ESTIMATED)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06614010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06614010, "Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06614010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*